Bederra marks first medical buy with Diagnos' imaging tech
This article was originally published in Clinica
Executive Summary
Equipment leasing company Bederra has acquired diagnostic imaging company Diagnos in exchange for 15 million shares. The deal, which saw Diagnos become a wholly-owned subsidiary of Bederra on December 27 2007, enables the Texas, Houston-based acquirer to offer its customers PET technology designed to detect cancer, Alzheimer's disease, dementia and heart disease. Diagnos' technology currently only has an installed base of 18 units all within the Houston area. The company will hope the Bederra deal opens up new sales routes to more states for the technology. The PET technology is accepted by Medicare and all private insurance carriers. President of Bederra Graham Williams said this acquisition marked the first of many acquisitions in the medical sector that the company had planned in the coming years. According to Bederra, the equipment leasing market generates revenues of around $200bn every year.